CoChat

Metabolic Syndrome and Robustness Tradeoffs

Open access
Kitano, Hiroaki, Oda, Kanae, Kimura, Tomomi, Matsuoka, Yukiko, Csete, Marie, Doyle, John, Muramatsu, Masaaki · 2004 · Diabetes
Cited by 146

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The metabolic syndrome is a highly complex breakdown of normal physiology characterized by obesity, insulin resistance, hyperlipidemia, and hypertension. Type 2 diabetes is a major manifestation of this syndrome, although increased risk for cardiovascular disease (CVD) often precedes the onset of frank clinical diabetes. Prevention and cure for this disease constellation is of major importance to world health. Because the metabolic syndrome affects multiple interacting organ systems (i.e., it is a systemic disease), a systems-level analysis of disease evolution is essential for both complete elucidation of its pathophysiology and improved approaches to therapy. The goal of this review is to provide a perspective on systems-level approaches to metabolic syndrome, with particular emphasis on type 2 diabetes. We consider that metabolic syndromes take over inherent dynamics of our body that ensure robustness against unstable food supply and pathogenic infections, and lead to chronic inflammation that ultimately results in CVD. This exemplifies how trade-offs between robustness against common perturbations (unstable food and infections) and fragility against unusual perturbations (high–energy content foods and low–energy utilization lifestyle) is exploited to form chronic diseases. Possible therapeutic approaches that target fragility of emergent robustness of the disease state have been discussed. A detailed molecular interaction map for adipocyte, hepatocyte, skeletal muscle cell, and pancreatic β-cell cross-talk in the metabolic syndrome can be viewed at http://www.systems-biology.org/001/003.html.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.53.suppl_3.s6

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 146

Metadata

Authors
Kitano, H., Oda, K., Kimura, T., Matsuoka, Y., Csete, M., Doyle, J., & Muramatsu, M.
Venue
Diabetes
Published
2004-12-01
Volume
53
Issue
suppl_3
Pages
S6-S15
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2129618124
Cited by
146
References
19
FWCI
9.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Syndrome and Robustness Tradeoffs. https://app.cochat.ai/papers/10.2337/diabetes.53.suppl_3.s6
The paper
Kitano, H., Oda, K., Kimura, T., Matsuoka, Y., Csete, M., Doyle, J., & Muramatsu, M. (2004). Metabolic Syndrome and Robustness Tradeoffs. Diabetes. https://doi.org/10.2337/diabetes.53.suppl_3.s6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.